Broom Colin MD 4
4 · Nabriva Therapeutics plc · Filed Aug 4, 2022
Insider Transaction Report
Form 4
Broom Colin MD
Chief Executive Officer
Transactions
- Sale
Ordinary Shares
2022-08-02$0.19/sh−5,339$1,015→ 36,523 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1902 to $0.1911, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.